scispace - formally typeset
S

Stefan Vallo

Researcher at Goethe University Frankfurt

Publications -  42
Citations -  567

Stefan Vallo is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Cystectomy & Cisplatin. The author has an hindex of 14, co-authored 38 publications receiving 483 citations. Previous affiliations of Stefan Vallo include Heidelberg University.

Papers
More filters
Journal ArticleDOI

Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (−)-Gossypol (AT-101)

TL;DR: These findings show for the first time that (−)-gossypol concomitantly triggers apoptosis and a cytoprotective type of autophagy in bladder cancer and support the notion that enhanced autophile may underlie the chemoresistant phenotype of these tumors.
Journal ArticleDOI

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics

TL;DR: In this paper, the authors evaluated the activity of the drug transporter ATP-binding cassette transporter, subfamily B, member 1 (ABCB1, a critical mediator of multidrug resistance in cancer) using fluorescent ABCB1 substrates.
Journal ArticleDOI

Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?

TL;DR: Quality, accessibility, and usability of websites on prostate cancer provided a high rating in the current analysis, which is encouraging in view of the growing frequency of patients’ access of health information online.
Journal ArticleDOI

Technical characterization of a new bipolar and multipolar radiofrequency device for minimally invasive treatment of renal tumours

TL;DR: To investigate the technical characteristics of a newly developed device for bipolar and multipolar radiofrequency ablation (RFA) of kidney tissue with a resistance‐controlled power output, a novel approach is proposed.
Journal ArticleDOI

HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.

TL;DR: VPA exerted growth-blocking properties on a panel of bladder cancer cell lines, commensurate with dose and exposure time and should be considered when designing therapeutic strategies for treating bladder carcinoma.